Synthetic Data Investors

DataTribe is a cybersecurity startup foundry that invests in and co-builds dominant companies focused on generational leaps in cybersecurity and data science. Founded in 2015 and headquartered in Fulton, Maryland, DataTribe leverages deep experience and expertise to build and launch successful product companies. The team comprises former founders, high-level executives, and alumni of the U.S. intelligence community, offering a unique blend of skills and insights to support entrepreneurs in developing next-generation cyber techniques and products. DataTribe's commitment to startup success includes providing significantly more early-stage capital than traditional investors and incubators, along with approximately $1 million in invaluable in-kind services, such as free office space and exclusive rates for legal, accounting, IT, and more. The firm also offers strategic guidance in areas like product management, go-to-market strategies, lead generation, and marketing, working alongside portfolio companies to chart their course from startup to market leader. Additionally, DataTribe stands at the crossroads of three powerful networks: executives at leading global companies, the dynamic Bay Area venture capital community, and the esteemed Intelligence Community and national labs, expediting portfolio companies' journey to market success while bolstering access to talent and capital.

We invest in startups that are helping companies realise the value in automation.

Updata Partners provides growth capital to software and software-enabled businesses. Led by an investment team averaging more than 25 years of technology experience, we invest in high-growth businesses where the combination of our capital and operating experience will help accelerate success. As former executives and entrepreneurs, Updata’s General Partners collaborate with management teams to build companies that stand out in their markets. With more than $750 million of committed capital since inception, we have provided growth equity funding to over 40 leading technology companies.Updata invests in sectors we know well and in markets that we believe have high growth prospects. Companies in the “growth equity” stage have matured from idea to product development, have recorded meaningful sales, and have demonstrable proof points of market size and customer success. Capital is required to scale operations, expand to new markets, accelerate a new product launch, or provide liquidity to a founder or early investor. These situations are typically too large or complex for early-stage venture investors, and too small for later-stage private equity firms.

The Data Venture is a venture capital firm specializes in seed stage and startups investments. The firm seeks to invest in deep- tech fields such as decentralization, cryptography and blockchain. It typically invests in Europe. The firm initially invests between €0.5 million ($0.58 million) to €1.5 million ($1.74 million) in data-driven companies. The Data Venture is headquartered in Barcelona, Spain.

At Data Point Capital, we invest in revenue-stage technology companies that are disrupting large markets across both B2B and B2C. We specifically target businesses that are both capital efficient and high growth. As former operators, our experience helps us guide entrepreneurs to realize their vision.

DataPower Ventures is a Venture Capital firm that invests in data products, applied AI, infrastructure, and deep tech startups, primarily focusing on the New York City and Silicon Valley ecosystems.

Frost Data Capital is a venture capital firm specializing in start-up investments, early stage startups, and incubation. It prefers to invest in big data analytics, health technology, and industrials. Frost Data Capital is based in San Juan Capistrano, California.

Databricks Ventures is the strategic investment arm of Databricks, focusing on fostering innovation in data, analytics, and AI. Established in December 2021, its inaugural fund, the Lakehouse Fund, targets early- and growth-stage companies that enhance the lakehouse ecosystem or utilize its architecture to develop next-generation data and AI solutions. Portfolio companies benefit from exclusive product roadmap access, deep technical integrations, and go-to-market support, leveraging the growing momentum of the lakehouse ecosystem. Databricks Ventures seeks investments in projects and entrepreneurs committed to open platforms, aligning with Databricks' dedication to open-source development. The fund operates without a cap, aiming to support the most innovative companies and technologies for the long-term benefit of the industry and customers. Investments are directed toward startups raising early- to growth-stage funding rounds led by institutional venture capital firms.

MLS Capital Fund II (MLSCF II), co-managed by Spruce Capital Partners and Xeraya Capital, will invest the funds in a diversified portfolio of biogreentech companies at all stages of development. Biogreentech spans plant and animal agriculture; food, feed, and nutrition; bio-renewable chemicals and materials; and adjacent opportunities along the value chain, including “big data" analytics, robotics, production, harvesting and use of natural resources, and synthetic biology.

We invest in high performance healthcare companies at the convergence of technology and biology. We focus on 4 key themes: connectivity, platform innovation, payments and deep technology. This includes: distributed care, virtual care, wearables, patient empowerment, artificial intelligence, mental health and holistic care solutions, chronic disease management, data analysis, alternative drug pricing, value-based care, care efficiency, preventative medicine, synthetic biology, nanotechnology, personalized medicine, gene editing, and more

RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. The firm is a stage agnostic, with seed to sale, although it prefers to invest in series A to C rounds. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies and sectors like agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software and data, hardware, consumer products and accessories, wellness products, retail and distribution, and media and content. The firm also focuses on beverages, capsules and concentrates, edibles, dry flower / pre-rolls, vaporizers and hardware, pet products, and topicals. In agriculture and food sciences firm focuses in invest plant science, soil science, food science, animal science and environmental science. In production firm focuses in Indoor cultivation, greenhouse cultivation, outdoor cultivation, nursery cultivation and fermentation. In processing firm focuses in harvesting, extraction and purification, packaging, food and beverage processing and laboratory testing services. In pharmaceuticals and biotechnology firm focuses in pharmaceutical discovery and development, delivery method (ex: pill, soft gel, tincture), biosynthetic derived cannabinoids and other molecules, medical devices (ex: inhalers) and lab equipment. In consumer products and accessories firm focuses in edibles, beverages, inhalable, cosmetics and cannabis consumption accessories. In retail and distribution firm focuses in licensed brick and mortar retailers, pharmacies, online consumer marketplaces, delivery services, and others. The firm invests in opportunities globally. The firm prefers to invest in check sizes have ranged from CA$1 million ($0.71 million) to CA$40 million ($28.45 million), but more typical investment range is between CA$5 million ($3.6 million) to CA$10 million ($7.1 million). The firm is focused on making minority stake investments. Firm employ diverse investment structures including debt, preferred and common equity, and production-linked royalties. RIV Capital Inc. was founded on 2017 and is based in Toronto, Canada.

Acrobator Ventures is a relationship-first venture capital firm specializing in early-stage investments, particularly at the pre-seed and seed stages. The firm focuses on sectors such as B2B(2C) AI/ML software, including cybersecurity, fintech, infrastructure, synthetic media, and data-intensive technologies. Geographically, Acrobator Ventures targets founders from the Commonwealth of Independent States (CIS), the Baltics, and Central and Eastern Europe (CEE) who are building global software platforms. The firm typically invests between $200,000 and $1.25 million in initial funding, often taking a lead investor role, and continues to support companies through subsequent funding rounds (A, B, C). Acrobator Ventures brings a wealth of expertise, having built businesses themselves, led over 150 developers on SaaS and large-scale AI/ML projects, scaled a SaaS company, and invested across various regions and cultures. They emphasize founder coaching and are committed to supporting entrepreneurs throughout their journey.

Artis Ventures is a pioneering venture capital firm dedicated to investing in the convergence of technology, biology, and health—collectively termed "Tech Bio+Health." As the first fund globally to deploy capital in this transformative sector, Artis Ventures focuses on companies that leverage data, software, AI, machine learning, and deep learning to revolutionize human health and well-being. The firm coined and trademarked the term "TechBio" to signify a new era in medicine, where advancements in sequencing, computing, data management, and synthetic biology are reshaping healthcare approaches. With a global perspective, Artis Ventures aims to invest in scalable medical technologies that can improve health outcomes and cure diseases worldwide. Their portfolio includes data-driven life sciences companies addressing everyday health challenges through engineering-first approaches, personalized therapeutics, and efficient drug discovery.

Ten VC Management, LLC is a venture capital firm specializing in pre-seed & seed stage investments. The firm focuses on scalable biomanufacturing, next-generation chemistry, biotech/techbio, synthetic biology, AI/ML for life sciences, exponential automation, advanced manufacturing and supply chains, autonomous machines and applied systems, integrated compliance, fintech/insurtech 2.0, advanced computing, big data storage and processing, transformational development tools, cybersecurity and defense, energy transition, natural resources, profitable sustainability, longevity & space tech. Ten VC Management, LLC is headquartered in United States.

Shanghai Zhongping Capital Co. Ltd. is a private equity and venture capital firm specializing in growth stage, expansion stage, industry consolidation, and buyout investments. It seeks to invest in the field of life science, advanced manufacturing, new material, big consumer, environmental new energy, technology, media, telecommunication, and financial services. For technology, media and telecommunications, it includes artificial intelligence, big data, fintech, 5G industry chain, enterprise services, Internet of things, and autonomous driving; For life science, it includes innovative drugs, synthetic biology, medical devices, consumer healthcare, Internet healthcare, hospital management groups, biotechnology, pharmaceutical research and development foundry; For new energy and material, this includes new energy vehicle, new power battery, photovoltaic, wind power, hydrogen energy, nuclear power, energy saving, environmental protection and frontier new materials; For advanced manufacturing, it includes robots and core components, industrial automation, aerospace, sensors, intelligent equipment, digital factories, high-end equipment manufacturing and industrial Internet; For big consumer, this includes emerging brands, cultural experience, smart logistics, digital transformation, medical beauty, healthy consumption and vertical e-commerce channels. The firm seeks to invests in China. It also invest in European and American firms that is highly associated with Greater China. The firm seeks to invests around RMB 300 million to RMB 1 billion per portfolio company. Shanghai Zhongping Capital Co. Ltd. was founded in 2016 and is based in Shanghai, China.